Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-18-012817
Filing Date
2018-03-09
Accepted
2018-03-09 16:16:41
Documents
98
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1520932
2 EXHIBIT 10.8 ex10_8.htm EX-10.8 33969
3 EXHIBIT 12.1 ex12_1.htm EX-12.1 32485
4 EXHIBIT 23.1 ex23_1.htm EX-23.1 3292
5 EXHIBIT 24.1 ex24_1.htm EX-24.1 17262
6 EXHIBIT 31.1 ex31_1.htm EX-31.1 12808
7 EXHIBIT 31.2 ex31_2.htm EX-31.2 12093
8 EXHIBIT 32.1 ex32_1.htm EX-32.1 6720
9 EXHIBIT 32.2 ex32_2.htm EX-32.2 6535
16 image00001.jpg GRAPHIC 31929
  Complete submission text file 0001140361-18-012817.txt   8146956

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT rnn-20171231.xml EX-101.INS 2012473
11 XBRL TAXONOMY EXTENSION SCHEMA rnn-20171231.xsd EX-101.SCH 67582
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnn-20171231_cal.xml EX-101.CAL 50735
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnn-20171231_def.xml EX-101.DEF 200614
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnn-20171231_lab.xml EX-101.LAB 458852
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnn-20171231_pre.xml EX-101.PRE 407494
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34079 | Film No.: 18680246
SIC: 2834 Pharmaceutical Preparations